Maynard Um
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) PT Raised to $77 at BofA Securities
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) PT Raised to $89 at Stifel
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) Misses Q4 EPS by 12c
-
-
-
-
-
-
-
TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) Tops Q2 EPS by $2.06
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) PT Lowered to $60 at Stifel
-
-
-
-
-
-
-
Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c
-
401,763 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

